Sanofi Group Associate Director, Dupilumab Publications in Cambridge, Massachusetts

The Associate Director of Medical Publications will be accountable for development and implementation of strategic publication plans for Dupilumab (Dupixent) in respiratory indications. The ideal candidate will have significant publications management experience and a clear understanding of publication strategy and planning for both marketed products as well as products in clinical development. Long-term budget, vendor, and resource allocation management experience are necessary, in addition to expertise in the policies and best practices governing publications globally. Candidates must possess the ability to direct multiple complex projects.

This role with be part of the broader Scientific Communications Team supporting Immunology & Inflammation Medical Affairs at Sanofi Genzyme. Sanofi co-develops Dupilumab with Regeneron Pharmaceutical, a US-integrated biopharmaceutical Company based in Tarrytown, NY. The two companies have a major global collaboration to discover, develop, and commercialize fully human therapeutic antibodies. Therefore, the Associate Director of Medical Publications must be able to establish excellent working relationships and credibility within the Sanofi & Regeneron Alliance Pharmaceutical Team.

JOB RESPONSIBILITIES:

  • Lead the development and execution of global publications plans for Dupilumab in respiratory indications, with a strong understanding of how publications support the overall Development, Medical, and Commercial strategies

  • Establish and maintain collaborative relationships with cross-functional stakeholders and KOLs (key opinion leaders) to facilitate collaborative, strategic publication planning

  • Maintain accurate and up-to-date records on publication activities within the Datavision system

  • Oversee development, review, and approval of publications on company sponsored studies

  • Oversee appropriate reviews of publications resulting from research collaborations and independent company-supported investigator-sponsored studies (ISTs)

  • Participate in the review of manuscripts, abstracts, and presentations to ensure accuracy, appropriateness, and alignment with scientific communication and data disclosure strategies

  • Serve as an expert on publications best practices, company processes/SOPs, and on industry publications standards, including GPP3 and ICMJE

  • Foster an in depth understanding of respiratory therapeutic area and treatment landscape, reviewing emerging literature and communicating insights to inform strategic planning

  • Participate in long-range planning exercises; develop and manage project plans, assess resource needs, and develop and implement processes and standards

  • Contribute to the development of Global and Regional Medical Affairs/Communications strategies and planning

  • Communicate trends and progress against plans updates to leadership and key stakeholders

BASIC QUALIFICATIONS:

· Advanced Scientific/Medical degree (i.e. PhD, MD, PharmD, MS, MPH)

· 5-10 years scientific writing, communications, and/or publications experience

· Minimum of 5 years pharma/biotech industry global or US publications experience

· Strong analytical and communication skills, both oral and written

PREFERRED QUALIFICATIONS:

· Doctorate level Scientific/Medical degree (i.e. PhD, MD, PharmD)

· CMPP certification

· Medical/Scientific/Clinical background

· Experience in Asthma and/or other respiratory areas

· Knowledge of GPP3 and ICMJE

· Experience in Strategic Publication planning in support of product launch

· Enthusiastic, detail-oriented, strategic and collaborative

· Approximately 20% travel required

Sanofi is a global healthcare leader focused on patients' needs, engaged in the research, development, manufacturing and marketing of therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and Sanofi Genzyme.

At Sanofi, our ambition is to be an integrated global healthcare company, focused on patients’ needs. Much more than just a leading pharmaceutical company, Sanofi is committed to transforming scientific innovations into solutions and services that protect health, enhance life, and respond to the needs of the 7 billion people in the world. We trust our ambition to guide and inspire us as we work to create a future with optimal health and wellness for everyone.

Sanofi is a global healthcare leader focused on patients' needs, engaged in the research, development, manufacturing and marketing of therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and Sanofi Genzyme.